...
首页> 外文期刊>Pharmacogenetics and genomics >Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine ('Ecstasy') cytotoxicity.
【24h】

Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine ('Ecstasy') cytotoxicity.

机译:CYP2D6多态性对3,4-亚甲基二氧基甲基苯丙胺('摇头丸')细胞毒性的影响。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: Remarkable interindividual differences in 3,4-methylenedioxymethamphetamine ('Ecstasy')-mediated toxicity have been reported in humans. Therefore, we tested whether CYP2D6 or its variant alleles as well as CYP3A4 influence the susceptibility to 3,4-methylenedioxymethamphetamine. METHODS: 3,4-Methylenedioxymethamphetamine cytotoxicity was determined in V79 cells expressing human wild-type CYP2D6 (CYP2D6*1), the low-activity alleles CYP2D6*2, *9, *10, and *17, as well as human CYP3A4. Metabolites of 3,4-methylenedioxymethamphetamine formed by the different cell lines were quantified by high-performance liquid chromatography/electrochemical detector. RESULTS: Toxicity of 3,4-methylenedioxymethamphetamine was clearly increased in cells expressing CYP2D6*1 compared with the parental cells devoid of CYP-dependent enzymatic activity. Toxicity in V79 CYP2D6*1 cells was also higher than in V79 cell lines expressing the low-activity alleles CYP2D6*2, *9, *10, or *17. In contrast to CYP2D6, the CYP3A4isoenzyme did not enhance 3,4-methylenedioxymethamphetamine toxicity. Formation of the oxidative 3,4-methylenedioxymethamphetamine metabolite N-methyl-alpha-methyldopamine was greatly enhanced in V79 cell line transfected with CYP2D6*1 compared to all other cell lines. The increase in the cytotoxic effects of 3,4-methylenedioxymethamphetamine observed in this cell line was therefore suspected to be a consequence of the production of this metabolite. This was further investigated by testing the cytotoxicity of N-methyl-alpha-methyldopamine to the control cell line. The results confirmed our hypothesis as the metabolite proved to be more than 100-fold more toxic than the parent compound 3,4-methylenedioxymethamphetamine. CONCLUSIONS: CYP2D6*1 mediates 3,4-methylenedioxymethamphetamine toxicity via formation of N-methyl-alpha-methyldopamine. Therefore, it will be important to investigate whether CYP2D6 ultrarapid metabolizers are overrepresented in the cases of 3,4-methylenedioxymethamphetamine intoxications.
机译:目的:已报道人类在3,4-亚甲基二氧基甲基苯丙胺(“迷魂药”)介导的毒性方面存在显着个体差异。因此,我们测试了CYP2D6或其变异等位基因以及CYP3A4是否会影响对3,4-亚甲基二氧基甲基苯丙胺的敏感性。方法:在表达人野生型CYP2D6(CYP2D6 * 1),低活性等位基因CYP2D6 * 2,* 9,* 10和* 17以及人CYP3A4的V79细胞中测定3,4-亚甲二氧基甲基苯丙胺的细胞毒性。通过高效液相色谱/电化学检测器对由不同细胞系形成的3,4-亚甲基二氧基甲基苯丙胺的代谢产物进行定量。结果:与没有CYP依赖性酶活性的亲本细胞相比,表达CYP2D6 * 1的细胞对3,4-亚甲二氧基甲基苯丙胺的毒性明显增加。 V79 CYP2D6 * 1细胞的毒性也高于表达低活性等位基因CYP2D6 * 2,* 9,* 10或* 17的V79细胞系。与CYP2D6相反,CYP3A4同工酶没有增强3,4-亚甲二氧基甲基苯丙胺的毒性。与其他所有细胞系相比,在用CYP2D6 * 1转染的V79细胞系中,氧化3,4-亚甲二氧基甲基苯丙胺代谢产物N-甲基-α-甲基多巴胺的形成大大增强。因此,怀疑在该细胞系中观察到的3,4-亚甲基二氧基甲基苯丙胺的细胞毒性作用增加是该代谢产物产生的结果。通过测试N-甲基-α-甲基多巴胺对对照细胞系的细胞毒性进一步研究了这一点。结果证实了我们的假设,因为代谢物被证明比母体化合物3,4-亚甲二氧基甲基苯丙胺的毒性高100倍以上。结论:CYP2D6 * 1通过形成N-甲基-α-甲基多巴胺介导3,4-亚甲基二氧基甲基苯丙胺的毒性。因此,重要的是研究在3,4-亚甲基二氧基甲基苯丙胺中毒的情况下CYP2D6超快速代谢者是否过高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号